Fecal Microbiota Transplantation in the Treatment of Major LARS
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking University People's Hospital
About this trial
Randomized trial to assess FMT efficacy in improving bowel function for major LARS patients. 40 subjects, blinded, randomized to FMT or probiotics. Pre-post 16S sequencing, 4-week follow-up for bowel symptoms, 8-week microbiota analysis.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- fecal microbiota transplantation
- Formulated probiotic supplements
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Peking University People's Hospital
Lead sponsor
Source ClinicalTrials.gov